Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells

Journal of Cellular Biochemistry

Volumn 112, Issue 9, 2011, Pages 2340-2351

  Yong, Thomas ^a   Sun, Amanda ^a   Henry, Michael D ^b   Meyers, Shari ^c   Davis, J Nathan ^c  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Breast cancer; CBF1; CSL; NOTCH; Prostate cancer; RBP j ; Signal transduction; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; DELTA LIKE 1 PROTEIN; DELTEX 1 PROTEIN; DNA; GAMMA SECRETASE INHIBITOR; LMO2 PROTEIN; NOTCH RECEPTOR; SHORT HAIRPIN RNA; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CSL; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LENTIVIRINAE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; MALE; MICE; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; REGULATORY SEQUENCES, NUCLEIC ACID; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84860391815     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23157     Document Type: Article

References (46)

1. Artavanis-Tsakonas S, Matsuno K, Fortini ME,. 1995. Notch signaling. Science 268: 225-232.
2. Berezovska O, Jack C, McLean P, Aster JC, Hicks C, Xia W, Wolfe MS, Kimberly WT, Weinmaster G, Selkoe DJ, Hyman BT,. 2000. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling. J Neurochem 75: 583-593. (Pubitemid 30485439)
3. Bolos V, Grego-Bessa J, de la Pompa JL,. 2007. Notch signaling in development and cancer. Endocr Rev 28: 339-363. (Pubitemid 46984831)
4. Borggrefe T, Oswald F,. 2009. The Notch signaling pathway: Transcriptional regulation at Notch target genes. Cell Mol Life Sci 66: 1631-1646.
5. Bray SJ,. 2006. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689. (Pubitemid 44268213)
6. Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D,. 2003. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood 102: 3980-3988. (Pubitemid 37486979)
7. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R,. 1999. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522.
8. Dohda T, Maljukova A, Liu L, Heyman M, Grander D, Brodin D, Sangfelt O, Lendahl U,. 2007. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp Cell Res 313: 3141-3152. (Pubitemid 47161022)
9. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J,. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661. (Pubitemid 121001701)
10. Fernandez-Majada V, Aguilera C, Villanueva A, Vilardell F, Robert-Moreno A, Aytes A, Real FX, Capella G, Mayo MW, Espinosa L, Bigas A,. 2007. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci USA 104: 276-281. (Pubitemid 46068022)
11. Gorman MJ, Girton JR,. 1992. A genetic analysis of deltex and its interaction with the Notch locus in Drosophila melanogaster. Genetics 131: 99-112.
12. Han J, Ma I, Hendzel MJ, Allalunis-Turner J,. 2009. The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. Breast Cancer Res 11: R57.
13. Hare NJ, Ma CS, Alvaro F, Nichols KE, Tangye SG,. 2006. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP. Int Immunol 18: 1055-1065. (Pubitemid 43923424)
14. Hopfer O, Zwahlen D, Fey MF, Aebi S,. 2005. The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer 93: 709-718. (Pubitemid 41486463)
15. Izon DJ, Aster JC, He Y, Weng A, Karnell FG, Patriub V, Xu L, Bakkour S, Rodriguez C, Allman D, Pear WS,. 2002. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 16: 231-243. (Pubitemid 34211963)
16. Kopan R, Ilagan MX,. 2009. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 137: 216-233.
17. Kovall RA,. 2008. More complicated than it looks: Assembly of Notch pathway transcription complexes. Oncogene 27: 5099-5109.
18. Kuroda K, Han H, Tani S, Tanigaki K, Tun T, Furukawa T, Taniguchi Y, Kurooka H, Hamada Y, Toyokuni S, Honjo T,. 2003. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 18: 301-312. (Pubitemid 36263003)
19. Lee SY, Kumano K, Nakazaki K, Sanada M, Matsumoto A, Yamamoto G, Nannya Y, Suzuki R, Ota S, Ota Y, Izutsu K, Sakata-Yanagimoto M, Hangaishi A, Yagita H, Fukayama M, Seto M, Kurokawa M, Ogawa S, Chiba S,. 2009. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci 100: 920-926.
20. Matsuno K, Eastman D, Mitsiades T, Quinn AM, Carcanciu ML, Ordentlich P, Kadesch T, Artavanis-Tsakonas S,. 1998. Human deltex is a conserved regulator of Notch signalling. Nat Genet 19: 74-78. (Pubitemid 28242028)
21. Matsuno K, Ito M, Hori K, Miyashita F, Suzuki S, Kishi N, Artavanis-Tsakonas S, Okano H,. 2002. Involvement of a proline-rich motif and RING-H2 finger of Deltex in the regulation of Notch signaling. Development 129: 1049-1059. (Pubitemid 34874128)
22. Meyers S, Downing JR, Hiebert SW,. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13: 6336-6345. (Pubitemid 23292627)
23. Miele L, Miao H, Nickoloff BJ,. 2006. NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets 6: 313-323. (Pubitemid 43961866)
24. Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SD,. 2003. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3: 565-576. (Pubitemid 36808651)
25. Nickoloff BJ, Osborne BA, Miele L,. 2003. Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifying agents. Oncogene 22: 6598-6608. (Pubitemid 37372340)
26. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP, Radtke F,. 2003. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33: 416-421. (Pubitemid 36278861)
27. Oswald F, Kostezka U, Astrahantseff K, Bourteele S, Dillinger K, Zechner U, Ludwig L, Wilda M, Hameister H, Knochel W, Liptay S, Schmid RM,. 2002. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. EMBO J 21: 5417-5426. (Pubitemid 35231021)
28. Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih Ie M, Wang TL,. 2006. Notch3 gene amplification in ovarian cancer. Cancer Res 66: 6312-6318.
29. Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G, Di Fiore PP,. 2004. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167: 215-221. (Pubitemid 39435065)
30. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G, Egan SE,. 2005. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65: 8530-8537. (Pubitemid 41330622)
31. Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, Dickson BC, Lockwood G, Gallinger S, Egan SE,. 2008. Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 33: 1223-1229.
32. Rosati E, Sabatini R, Rampino G, Tabilio A, Di Ianni M, Fettucciari K, Bartoli A, Coaccioli S, Screpanti I, Marconi P,. 2009. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 113: 856-865.
33. Salat D, Liefke R, Wiedenmann J, Borggrefe T, Oswald F,. 2008. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes. Mol Cell Biol 28: 3502-3512. (Pubitemid 351657111)
34. Santagata S, Demichelis F, Riva A, Varambally S, Hofer MD, Kutok JL, Kim R, Tang J, Montie JE, Chinnaiyan AM, Rubin MA, Aster JC,. 2004. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64: 6854-6857. (Pubitemid 39330990)
35. Scorey N, Fraser SP, Patel P, Pridgeon C, Dallman MJ, Djamgoz MB,. 2006. Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: Independent modulation of in vitro motility. Prostate Cancer Prostatic Dis 9: 399-406. (Pubitemid 44843133)
36. Svensson RU, Barnes JM, Rokhlin OW, Cohen MB, Henry MD,. 2007. Chemotherapeutic agents up-regulate the cytomegalovirus promoter: Implications for bioluminescence imaging of tumor response to therapy. Cancer Res 67: 10445-10454. (Pubitemid 350070820)
37. Wang XD, Shou J, Wong P, French DM, Gao WQ,. 2004. Notch1-expressing cells are indispensable for prostatic branching morphogenesis during development and re-growth following castration and androgen replacement. J Biol Chem 279: 24733-24744. (Pubitemid 38725341)
38. Wang XD, Leow CC, Zha J, Tang Z, Modrusan Z, Radtke F, Aguet M, de Sauvage FJ, Gao WQ,. 2006. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol 290: 66-80. (Pubitemid 43083604)
39. Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH,. 2010. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J Cell Biochem 109: 726-736.
40. Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH,. 2011. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. J Cell Biochem 112: 78-88.
41. Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM, Miele L,. 2002. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8: 979-986. (Pubitemid 35033702)
42. Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC,. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271. (Pubitemid 39336870)
43. Xu T, Artavanis-Tsakonas S,. 1990. Deltex, a locus interacting with the neurogenic genes, Notch, Delta and mastermind in Drosophila melanogaster. Genetics 126: 665-677. (Pubitemid 20372385)
44. Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K, Nakamura K, Weinmaster G, Okano H, Nakafuku M,. 2001. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J Biol Chem 276: 45031-45040.
45. Zayzafoon M, Abdulkadir SA, McDonald JM,. 2004. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. J Biol Chem 279: 3662-3670. (Pubitemid 38140608)
46. Zhang Y, Wang Z, Ahmed F, Banerjee S, Li Y, Sarkar FH,. 2006. Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells. Int J Cancer 119: 2071-2077. (Pubitemid 44423663)